<SEC-DOCUMENT>0001354457-25-001236.txt : 20251209
<SEC-HEADER>0001354457-25-001236.hdr.sgml : 20251209
<ACCEPTANCE-DATETIME>20251209152838
ACCESSION NUMBER:		0001354457-25-001236
CONFORMED SUBMISSION TYPE:	25-NSE
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20251209
DATE AS OF CHANGE:		20251209
EFFECTIVENESS DATE:		20251209

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Adverum Biotechnologies, Inc.
		CENTRAL INDEX KEY:			0001501756
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				205258327
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		25-NSE
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36579
		FILM NUMBER:		251558811

	BUSINESS ADDRESS:	
		STREET 1:		100 CARDINAL WAY
		CITY:			REDWOOD CITY
		STATE:			CA
		ZIP:			94063
		BUSINESS PHONE:		(650) 649-1004

	MAIL ADDRESS:	
		STREET 1:		100 CARDINAL WAY
		CITY:			REDWOOD CITY
		STATE:			CA
		ZIP:			94063

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Avalanche Biotechnologies, Inc.
		DATE OF NAME CHANGE:	20100921

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Nasdaq Stock Market LLC
		CENTRAL INDEX KEY:			0001354457
		ORGANIZATION NAME:           	
		EIN:				521165937
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		25-NSE

	BUSINESS ADDRESS:	
		STREET 1:		One Liberty Plaza
		CITY:			New York
		STATE:			NY
		ZIP:			10006
		BUSINESS PHONE:		301-978-4144

	MAIL ADDRESS:	
		STREET 1:		Office of General Counsel
		STREET 2:		805 King Farm Blvd.
		CITY:			ROCKVILLE
		STATE:			MD
		ZIP:			20850

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	The Nasdaq Stock Market LLC
		DATE OF NAME CHANGE:	20060224
</SEC-HEADER>
<DOCUMENT>
<TYPE>25-NSE
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0"?>
<notificationOfRemoval>

    <schemaVersion>X0203</schemaVersion>

    <exchange>
        <cik>0001354457</cik>
        <entityName>Nasdaq Stock Market LLC</entityName>
    </exchange>

    <issuer>
        <cik>0001501756</cik>
        <entityName>Adverum Biotechnologies, Inc.</entityName>
        <fileNumber>001-36579</fileNumber>
        <address>
            <street1>1035 O'Brien Drive, Suite A</street1>
            <street2></street2>
            <city>Menlo Park</city>
            <stateOrCountryCode>CA</stateOrCountryCode>
            <stateOrCountry>CALIFORNIA</stateOrCountry>
            <zipCode>94025</zipCode>
        </address>
        <telephoneNumber>(650) 272-2629</telephoneNumber>
    </issuer>

    <descriptionClassSecurity>Common Stock</descriptionClassSecurity>

    <ruleProvision>17 CFR 240.12d2-2(a)(3)</ruleProvision>

    <signatureData>
        <signatureName>Tara Petta</signatureName>
        <signatureTitle>Director</signatureTitle>
        <signatureDate>2025-12-09</signatureDate>
    </signatureData>
</notificationOfRemoval>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.25
<SEQUENCE>2
<FILENAME>advm-form25.txt
<TEXT>
Advm-form25






</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
